GL1X · GenesisL1 explorer

Research workbench

CGL2 in complex with linear B2 trisaccharide

Analyse CGL2 in complex with linear B2 trisaccharide in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1ULE
Type
protein
Length
300 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Galectin-2
Ligands
NAG, GAL, GLA
Pockets
2 · best druggability 0.62

Structure

x-ray diffraction · 1 distinct chain · 0% helix, 49% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BGalectin-2protein1500% helix, 49% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains A, B
  • GAL · beta-D-galactopyranose · sugar · 2 copies · chains A, B
  • GLA · alpha-D-galactopyranose · sugar · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11710.620.8441empty
21160.470.7918empty

Interfaces

1 interface between chains.

  • A–B · 981 Ų buried · 16 hydrogen bonds · protein-protein

Compared structures

  • 1ULE · CGL2 in complex with linear B2 trisaccharide · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.